guest ::
| Home > Publications database > Structure and potential functions of GABARAP > print |
| 001 | 6509 | ||
| 005 | 20200402205709.0 | ||
| 024 | 7 | _ | |2 pmid |a pmid:19674112 |
| 024 | 7 | _ | |2 DOI |a 10.1111/j.1742-4658.2009.07207.x |
| 024 | 7 | _ | |2 WOS |a WOS:000269366500001 |
| 037 | _ | _ | |a PreJuSER-6509 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 540 |
| 084 | _ | _ | |2 WoS |a Biochemistry & Molecular Biology |
| 100 | 1 | _ | |0 P:(DE-Juel1)132012 |a Mohrlüder, J. |b 0 |u FZJ |
| 245 | _ | _ | |a Structure and potential functions of GABARAP |
| 260 | _ | _ | |a Oxford [u.a.] |b Wiley-Blackwell |c 2009 |
| 300 | _ | _ | |a 4989 - 5005 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |0 17341 |a FEBS Journal |v 276 |x 1742-464X |y 18 |
| 500 | _ | _ | |a The authors thank Sameer Singh for carefully reading the manuscript. This study was supported by a fellowship of the International Helmholtz Research School BioSoft to M. Schwarten and a research grant from the Deutsche Forschungsgemeinschaft (DFG) to D. Willbold (Wi1472/5). |
| 520 | _ | _ | |a The gamma-aminobutyrate type A receptor-associated protein (GABARAP) is a ubiquitin-like modifier, and is implicated in a variety of membrane trafficking and fusion events that are crucial to synaptic plasticity, autophagy and apoptosis. However, important aspects of GABARAP function and regulation remain poorly understood. We review the current state of knowledge about GABARAP, highlighting newly-identified GABARAP ligands, and discuss the possible physiological relevance of each ligand interaction. |
| 536 | _ | _ | |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF) |a Funktion und Dysfunktion des Nervensystems |c P33 |x 0 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
| 650 | _ | 2 | |2 MeSH |a Adaptor Proteins, Signal Transducing: chemistry |
| 650 | _ | 2 | |2 MeSH |a Adaptor Proteins, Signal Transducing: physiology |
| 650 | _ | 2 | |2 MeSH |a Animals |
| 650 | _ | 2 | |2 MeSH |a Calreticulin: physiology |
| 650 | _ | 2 | |2 MeSH |a Carrier Proteins: physiology |
| 650 | _ | 2 | |2 MeSH |a Humans |
| 650 | _ | 2 | |2 MeSH |a Ligands |
| 650 | _ | 2 | |2 MeSH |a Membrane Proteins: physiology |
| 650 | _ | 2 | |2 MeSH |a Microfilament Proteins: physiology |
| 650 | _ | 2 | |2 MeSH |a Microtubule-Associated Proteins: chemistry |
| 650 | _ | 2 | |2 MeSH |a Microtubule-Associated Proteins: physiology |
| 650 | _ | 2 | |2 MeSH |a Nerve Tissue Proteins: physiology |
| 650 | _ | 2 | |2 MeSH |a Receptors, GABA-A: physiology |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Adaptor Proteins, Signal Transducing |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Calreticulin |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Carrier Proteins |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a GABARAP protein, human |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a GABARAPL2 protein, human |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a GABRG2 protein, human |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a GRIP1 protein, human |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Ligands |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Membrane Proteins |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Microfilament Proteins |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Microtubule-Associated Proteins |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Nerve Tissue Proteins |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Receptors, GABA-A |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a gephyrin |
| 650 | _ | 7 | |2 WoSType |a J |
| 653 | 2 | 0 | |2 Author |a apoptosis |
| 653 | 2 | 0 | |2 Author |a autophagy |
| 653 | 2 | 0 | |2 Author |a GABA(A) receptor |
| 653 | 2 | 0 | |2 Author |a GABARAP |
| 653 | 2 | 0 | |2 Author |a protein structure |
| 653 | 2 | 0 | |2 Author |a protein-protein interaction |
| 653 | 2 | 0 | |2 Author |a trafficking |
| 700 | 1 | _ | |0 P:(DE-Juel1)132019 |a Schwarten, M. |b 1 |u FZJ |
| 700 | 1 | _ | |0 P:(DE-Juel1)132029 |a Willbold, D. |b 2 |u FZJ |
| 773 | _ | _ | |0 PERI:(DE-600)2172518-4 |a 10.1111/j.1742-4658.2009.07207.x |g Vol. 276, p. 4989 - 5005 |p 4989 - 5005 |q 276<4989 - 5005 |t The @FEBS journal |v 276 |x 1742-464X |y 2009 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1111/j.1742-4658.2009.07207.x |
| 909 | C | O | |o oai:juser.fz-juelich.de:6509 |p VDB |
| 913 | 1 | _ | |0 G:(DE-Juel1)FUEK409 |a DE-HGF |b Gesundheit |k P33 |l Funktion und Dysfunktion des Nervensystems |v Funktion und Dysfunktion des Nervensystems |x 0 |
| 914 | 1 | _ | |y 2009 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed |
| 920 | 1 | _ | |d 31.12.2010 |g ISB |k ISB-3 |l Strukturbiochemie |0 I:(DE-Juel1)VDB942 |x 0 |
| 920 | 1 | _ | |0 I:(DE-82)080012_20140620 |k JARA-HPC |l Jülich Aachen Research Alliance - High-Performance Computing |g JARA |x 1 |
| 970 | _ | _ | |a VDB:(DE-Juel1)114821 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a I:(DE-82)080012_20140620 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| 981 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 981 | _ | _ | |a I:(DE-Juel1)VDB1346 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|